Skip to main content

Rhenman & Partners Asset Management AB

Source: SEC Form 13F · as of Mar 2026

Rhenman & Partners Asset Management AB holds 30 biotech & pharma companies tracked by BioSniper, totaling $247.8M in value as of Mar 2026 (SEC Form 13F).

Companies held

30

Total value held

$247.8M

BioSniper AIPage context preserved

Prepared research question

What matters most for REGENERON PHARMACEUTICALS, INC. (REGN)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
REGNREGENERON PHARMACEUTICALS, INC.48,100$37.2M
INSMINSMED Inc159,760$26.1M
GILDGILEAD SCIENCES, INC.167,750$23.4M
JAZZJazz Pharmaceuticals plc75,890$14.3M
BMRNBIOMARIN PHARMACEUTICAL INC207,000$11.7M
ALNYALNYLAM PHARMACEUTICALS, INC.34,465$11.4M
AXSMAxsome Therapeutics, Inc.63,800$10.8M
ADPTAdaptive Biotechnologies Corp720,000$10.0M
ARWRARROWHEAD PHARMACEUTICALS, INC.144,500$9.1M
NUVLNuvalent, Inc.81,200$8.3M
IOVAIOVANCE BIOTHERAPEUTICS, INC.2,055,327$7.2M
IONSIONIS PHARMACEUTICALS INC92,900$7.0M
DNTHDianthus Therapeutics, Inc. /DE/81,627$6.9M
BBIOBridgeBio Pharma, Inc.90,600$6.7M
APGEApogee Therapeutics, Inc.75,000$6.3M
GPCRStructure Therapeutics Inc.128,100$6.2M
VKTXViking Therapeutics, Inc.160,000$5.2M
NRIXNurix Therapeutics, Inc.313,500$4.9M
MLTXMoonLake Immunotherapeutics239,500$4.5M
NKTRNEKTAR THERAPEUTICS59,000$4.2M
DNLIDenali Therapeutics Inc.199,000$3.8M
RLAYRelay Therapeutics, Inc.360,000$3.6M
SIONSionna Therapeutics, Inc.87,500$3.5M
STOKStoke Therapeutics, Inc.83,000$2.7M
ESPREsperion Therapeutics, Inc.985,000$2.7M
IMCRImmunocore Holdings plc85,724$2.6M
OCULOCULAR THERAPEUTIX, INC305,000$2.6M
VCELVericel Corp70,000$2.3M
KURAKura Oncology, Inc.271,500$2.2M
CMPXCompass Therapeutics, Inc.115,113$609K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.